BioSpace News Archive

CANTEL MEDICAL CORP. announced that Peter Clifford, currently Executive Vice President and Chief Operating Officer, has been promoted to President and Chief Operating Officer.

Vanda Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration has accepted for priority review Vanda’s applications for Smith-Magenis Syndrome.

Schrödinger, whose physics-based software platform enables discovery of high-quality, novel molecules for therapeutics and materials, announced that it will host a conference call and webcast on Monday, August 10, 2020 at 8:30 a.m. ET to discuss second quarter 2020 financial results and provide a general business update.

Humanigen, Inc. , (OTCQB:HGEN) , announced today that the Company will host an investor call and webcast to discuss the National Institute of Health selection of lenzilumab

Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that it will report its second quarter 2020 financial results at the opening of U.S. financial markets on Monday, August 10, 2020. Neos management will host a conference call and live audio webcast to discuss these results and provide a company update at 8:30 a.m. E

-- Appointed David Meeker, M.D., as President and Chief Executive Officer – -- FDA granted rare pediatric disease designations for setmelanotide for the treatment of POMC and LEPR deficiency obesities -- -- Submitted MAA to EMA for setmelanotide in POMC and LEPR deficiency obesities -- -- Received FDA acceptance of NDA for setmelanotide for POMC and LEPR deficiency obesities for filing; assigned PDUFA goal date of November 27, 2020 – -- On track to announce topline data from pivotal

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo , will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference on Tuesday, August 11, 2020 at 3:30 p.m. ET. A live webcast of Intellia’s presentation will be accessible through the Events and Presentations page of the Investors & Media section of the co

Celldex Therapeutics, Inc. (Nasdaq:CLDX) will report second quarter 2020 financial results on Thursday, August 6, 2020 after the U.S. financial markets close. Celldex executives will host a conference call at 4:30 p.m. EDT on the same day to review the second quarter financial results and to provide an update on key research and development and business objectives for the remainder of 2020. The conference call and presentation will be webcast

Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing technologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, today announced that it has appointed Jeff Ramson as Senior Advisor, Capital Markets and Communications. Mr. Ramson will advise, coordinate, and assist in the implementation of Aditxt’s overall communica

Sysmex America, Inc., a leading diagnostic company offering hematology, urinalysis, information systems and flow cytometry testing solutions for optimal clinical laboratory performance, announced the availability of its new clinical software application, Caresphere™ Workflow Solution.